Probiotics for allergic diseases: realities and myths.
The prevalence of allergic diseases such as asthma, allergic rhinitis, and atopic dermatitis has increased sharply over the past two to three decades in many countries, and allergies are now the most common chronic disease among children throughout the world. In the past few years, probiotics have been advocated for the management of allergic diseases in many parts of the world. Physicians have a responsibility to ensure the efficacy and safety of any products they prescribe or recommend. This article provides a comprehensive overview and a critical interpretation of currently available evidence regarding the role of probiotics in the prevention and treatment of allergic diseases in humans and also discusses several major myths and potential risks associated with the use of probiotics. In the current era of evidence-based medicine, there is still insufficient evidence to recommend probiotics for the prevention of allergic diseases or as part of standard management for any allergic conditions in children.
Yao
Tsung-Chieh
TC
Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan. yao@adm.cgmh.org.tw
Chang
Chee-Jen
CJ
Hsu
Yi-Hsien
YH
Huang
Jing-Long
JL
D000818:Animals; D002648:Child; D019317:Evidence-Based Medicine; D006801:Humans; D006967:Hypersensitivity / Q000178:diet therapy* / Q000453:epidemiology / Q000276:immunology; D019936:Probiotics / Q000145:classification / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic